AngioDynamics Statistics
Share Statistics
AngioDynamics has 40.61M
shares outstanding. The number of shares has increased by 1.03%
in one year.
Shares Outstanding | 40.61M |
Shares Change (YoY) | 1.03% |
Shares Change (QoQ) | -0.41% |
Owned by Institutions (%) | 80.7% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 6,928 |
FTD / Avg. Volume | 1.38% |
Short Selling Information
The latest short interest is 1.49M, so 3.68% of the outstanding
shares have been sold short.
Short Interest | 1.49M |
Short % of Shares Out | 3.68% |
Short % of Float | 4.48% |
Short Ratio (days to cover) | 5.28 |
Valuation Ratios
The PE ratio is -1.38 and the forward
PE ratio is -41.39.
AngioDynamics's PEG ratio is
-0.01.
PE Ratio | -1.38 |
Forward PE | -41.39 |
PS Ratio | 0.83 |
Forward PS | 1 |
PB Ratio | 1.23 |
P/FCF Ratio | -7.47 |
PEG Ratio | -0.01 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for AngioDynamics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12,
with a Debt / Equity ratio of 0.03.
Current Ratio | 2.12 |
Quick Ratio | 1.46 |
Debt / Equity | 0.03 |
Debt / EBITDA | -0.41 |
Debt / FCF | -0.17 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $406,302.14 |
Profits Per Employee | $-246,455.88 |
Employee Count | 748 |
Asset Turnover | 0.96 |
Inventory Turnover | 2.46 |
Taxes
Income Tax | -7.29M |
Effective Tax Rate | 3.8% |
Stock Price Statistics
The stock price has increased by 51.42% in the
last 52 weeks. The beta is 0.58, so AngioDynamics's
price volatility has been higher than the market average.
Beta | 0.58 |
52-Week Price Change | 51.42% |
50-Day Moving Average | 9.46 |
200-Day Moving Average | 8.7 |
Relative Strength Index (RSI) | 53.44 |
Average Volume (20 Days) | 501,063 |
Income Statement
In the last 12 months, AngioDynamics had revenue of 303.91M
and earned -184.35M
in profits. Earnings per share was -4.59.
Revenue | 303.91M |
Gross Profit | 154.7M |
Operating Income | -192.44M |
Net Income | -184.35M |
EBITDA | -14.29M |
EBIT | -33.84M |
Earnings Per Share (EPS) | -4.59 |
Full Income Statement Balance Sheet
The company has 76.06M in cash and 5.91M in
debt, giving a net cash position of 70.14M.
Cash & Cash Equivalents | 76.06M |
Total Debt | 5.91M |
Net Cash | 70.14M |
Retained Earnings | -395.2M |
Total Assets | 285.42M |
Working Capital | 94.3M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -28.16M
and capital expenditures -5.77M, giving a free cash flow of -33.93M.
Operating Cash Flow | -28.16M |
Capital Expenditures | -5.77M |
Free Cash Flow | -33.93M |
FCF Per Share | -0.84 |
Full Cash Flow Statement Margins
Gross margin is 50.9%, with operating and profit margins of -63.32% and -60.66%.
Gross Margin | 50.9% |
Operating Margin | -63.32% |
Pretax Margin | -63.06% |
Profit Margin | -60.66% |
EBITDA Margin | -4.7% |
EBIT Margin | -63.32% |
FCF Margin | -11.16% |